Clinical Trial Update: Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating ketamine as a rapid-acting treatment for post-traumatic stress disorder (PTSD) has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Major Depressive Disorder
• Post-traumatic Stress Disorder
• Stress Disorders Post-traumatic

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Dennis Charney | Conditions: Stress Disorders, Post-Traumatic, PTSD | Phase 2 | Status: COMPLETED | Results posted: 2018-02-14